Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

被引:217
作者
Bauskin, Asne R.
Brown, David A.
Kuffner, Tamara
Johnen, Heiko
Luo, X. Wei
Hunter, Mark
Breit, Samuel N. [1 ]
机构
[1] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
关键词
D O I
10.1158/0008-5472.CAN-05-4067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Macrophage inhibitory cytokine-1 (MIC-1), a transforming growth factor-beta superfamily cytokine, is involved in tumor pathogenesis, and its measurement can be used as a clinical tool for the diagnosis and management of a wide range of cancers. Although generally considered to be part of the cell's antitumorigenic repertoire, MIC-1 secretion, processing, and latent storage suggest a complex, dynamic variability in MIC-1 bioavailability in the tumor microenvironment, potentially modulating tumor progression and invasiveness.
引用
收藏
页码:4983 / 4986
页数:4
相关论文
共 27 条
  • [1] Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1
    Albertoni, M
    Shaw, PH
    Nozaki, M
    Godard, S
    Tenan, M
    Hamou, MF
    Fairlie, DW
    Breit, SN
    Paralkar, VM
    de Tribolet, N
    Van Meir, EG
    Hegi, ME
    [J]. ONCOGENE, 2002, 21 (27) : 4212 - 4219
  • [2] Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein
    Baek, SJ
    Kim, JS
    Moore, SM
    Lee, SH
    Martinez, J
    Eling, TE
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (02) : 356 - 364
  • [3] Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities
    Baek, SJ
    Kim, KS
    Nixon, JB
    Wilson, LC
    Eling, TE
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (04) : 901 - 908
  • [4] The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome
    Bauskin, AR
    Brown, DA
    Junankar, S
    Rasiah, KK
    Eggleton, S
    Hunter, M
    Liu, T
    Smith, D
    Kuffner, T
    Pankhurst, GJ
    Johnen, H
    Russell, PJ
    Barret, W
    Stricker, PD
    Grygiel, JJ
    Kench, JG
    Henshall, SM
    Sutherland, RL
    Breit, SN
    [J]. CANCER RESEARCH, 2005, 65 (06) : 2330 - 2336
  • [5] MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
    Bootcov, MR
    Bauskin, AR
    Valenzuela, SM
    Moore, AG
    Bansal, M
    He, XY
    Zhang, HP
    Donnellan, M
    Mahler, S
    Pryor, K
    Walsh, BJ
    Nicholson, RC
    Fairlie, WD
    Por, SB
    Robbins, JM
    Breit, SN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11514 - 11519
  • [6] Expression of a novel member of the TGF-β superfamily, growth differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues
    Böttner, M
    Suter-Crazzolara, C
    Schober, A
    Unsicker, K
    [J]. CELL AND TISSUE RESEARCH, 1999, 297 (01) : 103 - 110
  • [7] Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis
    Brown, DA
    Stephan, C
    Ward, RL
    Law, M
    Hunter, M
    Bauskin, AR
    Amin, J
    Jung, K
    Diamandis, EP
    Hampton, GM
    Russell, PJ
    Giles, GG
    Breit, SN
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 89 - 96
  • [8] Brown DA, 2003, CLIN CANCER RES, V9, P2642
  • [9] Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
    Campbell, RA
    Bhat-Nakshatri, P
    Patel, NM
    Constantinidou, D
    Ali, S
    Nakshatri, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) : 9817 - 9824
  • [10] Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis
    Cheung, PK
    Woolcock, B
    Adomat, H
    Sutcliffe, M
    Bainbridge, TC
    Jones, EC
    Webber, D
    Kinahan, T
    Sadar, M
    Gleave, ME
    Vielkind, J
    [J]. CANCER RESEARCH, 2004, 64 (17) : 5929 - 5933